Hannah Fry

This profile gathers the share dealings of Hannah Fry in Protara Therapeutics, Inc. In total, 12 filings cover trades dated from 16 July 2022 to 26 January 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 27 January 2026 came the latest disclosure, a share grant for €8,195 in Protara Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.